Real-time enrollment status for this er+, her 2- breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:45 AM UTC
| NCT Number | NCT07540572 |
| Recruiting Status | Recruiting |
| Condition | ER+, HER 2- Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 160 participants |
| Active Locations | 11 sites in the US |
| Sponsor | IDEAYA Biosciences |
| Last Updated on CT.gov | June 16, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT07540572 is currently recruiting participants. This clinical trial study for er+, her 2- breast cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by IDEAYA Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07540572 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07540572 was last updated 3 weeks ago (June 16, 2026). HelloStudys verifies this status automatically.